Comparing Two Injection Sites of Local Anesthetic for Hand Surgery
NCT ID: NCT02112006
Last Updated: 2016-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-04-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Onset and Duration of Forearm Nerve Blockade
NCT03649763
The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery
NCT06806410
Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block
NCT06381622
Comparative Factorial Study Design of Ultrasound Guided Wrist Block for Hand Surgery Comparing Effect of Bupivacane Alone and Bupivacane with Dexamethasone and Bupivacane with Dexametmiodine and Bupivacane with Dexamethasone and Dexametmiodine
NCT06826690
A Comparative Study Between Arm Intravenous Regional Anesthesia Versus Forearm Intravenous Regional Anesthesia in Patients Undergoing Hand and Wrist Surgery
NCT06448845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
distal injection
0.5% bupivacaine injected in the forearm
0.5% bupivacaine injected in the forearm
Median, Ulnar, and Radial nerve blocks performed in the forearm
proximal injection
20-30ml of 0.5% bupivacaine
20-30ml of 0.5% bupivacaine.
supraclavicular, infraclavicular, or axillary nerve block using 20-30ml of 0.5% bupivacaine.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.5% bupivacaine injected in the forearm
Median, Ulnar, and Radial nerve blocks performed in the forearm
20-30ml of 0.5% bupivacaine.
supraclavicular, infraclavicular, or axillary nerve block using 20-30ml of 0.5% bupivacaine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand and provide informed consent
* American Society of Anesthesiologists (ASA) status I-III
Exclusion Criteria
* True allergy, not sensitivity, to any of the following substances: Local Anesthetics, Midazolam, Fentanyl, Hydromorphone, Propofol
* Pregnancy
* Severe hepatic impairment
* Evidence of infection at or near the proposed needle insertion site
* Any sensorimotor deficit of the ipsilateral upper extremity, whether acute or chronic, as determined by the PI and designee
* Pulmonary disease of any kind that is uncontrolled or severe in nature
* Chronic pain patients, defined as someone diagnosed with chronic pain or a chronic pain condition, under the care of a chronic pain physician, or taking oral/intravenous narcotics consistently for 30 days prior to surgery
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jose Soberon, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Soberon, MD
Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Soberon, MD
Role: PRINCIPAL_INVESTIGATOR
Ochsner Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soberon Forearm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.